Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 3/20 | 1.00 |
| ▸ | MAPK1 | P28482 | 5/20 | 0.97 |
| ▸ | MAPT | P10636 | 5/20 | 0.97 |
| ▸ | LMNA | P02545 | 4/20 | 0.97 |
| ▸ | GMNN | O75496 | 3/20 | 0.97 |
| ▸ | NPSR1 | Q6W5P4 | 3/20 | 0.97 |
| ▸ | MEN1 | O00255 | 3/20 | 0.97 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.97 |
| ▸ | TP53 | P04637 | 3/20 | 0.97 |
| ▸ | TSHR | P16473 | 3/20 | 0.97 |
| ▸ | HSP90AA1 | P07900 | 2/20 | 0.97 |
| ▸ | BLM | P54132 | 2/20 | 0.97 |
| ▸ | NR1H4 | Q96RI1 | 2/20 | 0.97 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.97 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.97 |
| ▸ | GLA | P06280 | 1/20 | 0.94 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.94 |
| ▸ | SLC25A20 | O43772 | 3/20 | 0.74 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.74 |
| ▸ | SLC6A5 | Q9Y345 | 2/20 | 0.74 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12648561 | 1.00 | CYP1A2 (1.00) | CYP1A2MAPK1MAPTLMNAGMNN | |
| Palmitoyl-Carnitine SCHEMBL20608769 | 0.98 | MAPK1 (1.00) | CYP1A2MAPK1MAPTLMNAGMNN | |
| SCHEMBL22392372 | 0.98 | MAPK1 (1.00) | CYP1A2MAPK1MAPTLMNAGMNN | |
| SCHEMBL21569424 | 0.98 | MAPK1 (1.00) | CYP1A2MAPK1MAPTLMNAGMNN | |
| SCHEMBL25373349 | 0.98 | MAPK1 (1.00) | CYP1A2MAPK1MAPTLMNAGMNN | |
| SCHEMBL25375657 | 0.98 | MAPK1 (1.00) | CYP1A2MAPK1MAPTLMNAGMNN | |
| SCHEMBL22206068 | 0.98 | MAPK1 (1.00) | CYP1A2MAPK1MAPTLMNAGMNN | |
| SCHEMBL21114352 | 0.98 | MAPK1 (1.00) | CYP1A2MAPK1MAPTLMNAGMNN | |
| SCHEMBL22392377 | 0.98 | MAPK1 (1.00) | CYP1A2MAPK1MAPTLMNAGMNN | |
| SCHEMBL22440885 | 0.98 | MAPK1 (1.00) | CYP1A2MAPK1MAPTLMNAGMNN |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12507703-B2 | Methods, devices and compositions for preserving human milk | THE TRUSTEES OF PRINCETON UNIVERSITY (US) | 2025-12-30 | — | — | US | disclosed |
| US-20250169516-A1 | METHODS, DEVICES AND COMPOSITIONS FOR PRESERVING HUMAN MILK | THE TRUSTEES OF PRINCETON UNIVERSITY (US) | 2025-05-29 | — | — | US | disclosed |
| US-12239142-B2 | Methods, devices and compositions for preserving human milk | THE TRUSTEES OF PRINCETON UNIVERSITY (US) | 2025-03-04 | — | — | US | disclosed |
| US-20240268402-A1 | Methods, Devices and Compositions for Preserving Human Milk | THE TRUSTEES OF PRINCETON UNIVERSITY (US) | 2024-08-15 | — | — | US | disclosed |
| CN-115825414-A | Blood or urine metabolic marker and application thereof in endometrial cancer early screening | 中国医学科学院北京协和医院 | 2023-03-21 | — | — | CN | disclosed |
| CN-109752473-B | Metabonomics analysis method taking amino acid and acylcarnitine as target in blood | 北京和合医学诊断技术股份有限公司 | 2022-04-01 | — | — | CN | disclosed |
| CN-109709248-B | Application of reagent and adsorption column in preparation of kit for detecting to-be-detected object in dried blood slice sample | 中国人民解放军总医院 | 2020-10-27 | — | — | CN | disclosed |
| CN-106537145-B | Small molecule biochemical profiling of individual subjects for disease diagnosis and health assessment | 麦特博隆股份有限公司 | 2020-08-25 | — | — | CN | disclosed |
| CN-110785664-A | Metabolites characteristic of abortion | 新加坡保健服务集团有限公司 | 2020-02-11 | — | — | CN | disclosed |
| CN-105492883-B | Two-phase electrowinning from mobile phases | 莱顿大学 | 2019-12-31 | — | — | CN | disclosed |
| US-20190391092-A1 | METABOLIC PROFILING WITH MAGNETIC RESONANCE MASS SPECTROMETRY (MRMS) | Oregon Institute of Science and Medicine | 2019-12-26 | — | — | US | disclosed |
| CN-108627647-A | A kind of detection of posttranslational modification proteomics and quantitative approach | 四川大学 | 2018-10-09 | — | — | CN | disclosed |
| CN-106537145-A | Small molecule biochemical profiling of individual subjects for disease diagnosis and health assessment | 麦特博隆股份有限公司 | 2017-03-22 | — | — | CN | disclosed |
| CN-105640931-A | acetoacetic monoglyceride for treating neurotic disorder and derivative thereof | 艾克塞拉公司 | 2016-06-08 | — | — | CN | disclosed |
| CN-102105071-A | Monoacetin esters of acetoacetate and derivatives thereof for the treatment of neurological disorders | NEUERA PHARMACEUTICALS INC | 2011-06-22 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12507703-B2 | Methods, devices and compositions for preserving human milk | LPL, CEL, LPO | CYP1A2 2244/4885MAPK1 4161/4885MAPT 1944/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.